5 min
COVID-19 & Oral Oncolytics CANCER BUZZ
-
- Science
On this mini-podcast, we explore how the COVID-19 pandemic has affected patient access to oral oncolytics, and what cancer teams can do to help their patients.
Guest: Lauren J. Sanders, PharmD, MTM Oncology Clinical Pharmacist, Oral Antineoplastics Program, The University of Arizona Cancer Center
Related Content:
ACCC COVID-19 Resource Center COVID-19 & Oral Oncolytics Transcript Oncology Pharmacy Education Network Integrating Oral Oncolytics into Pharmacy Practice “The Emerging Role of Oral Oncolytics,” by Ali McBride, PharmD, MS, BCOP “The Role of the Oral Oncology Nurse Navigator,” by Mary K. Anderson, BSN, RN, OCN, et al.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.
On this mini-podcast, we explore how the COVID-19 pandemic has affected patient access to oral oncolytics, and what cancer teams can do to help their patients.
Guest: Lauren J. Sanders, PharmD, MTM Oncology Clinical Pharmacist, Oral Antineoplastics Program, The University of Arizona Cancer Center
Related Content:
ACCC COVID-19 Resource Center COVID-19 & Oral Oncolytics Transcript Oncology Pharmacy Education Network Integrating Oral Oncolytics into Pharmacy Practice “The Emerging Role of Oral Oncolytics,” by Ali McBride, PharmD, MS, BCOP “The Role of the Oral Oncology Nurse Navigator,” by Mary K. Anderson, BSN, RN, OCN, et al.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.
5 min